Adaptive Biotechnologies is trading 6.9% up at $23.80 in after-hours trading, compared with a regular-session close of $22.27, despite a lack of specific company news.
- The move appears to be a liquidity-driven after-hours reaction rather than a response to earnings, M&A announcements, or FDA decisions.
- No major company-specific news was identified for July 24, 2026, amid a broader market that remains relatively mixed across major indices.